Immunocore (IMCR) Competitors $29.32 -0.32 (-1.08%) Closing price 04:00 PM EasternExtended Trading$29.30 -0.02 (-0.09%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMCR vs. TLX, BPMC, GRFS, NUVL, KRYS, VRNA, CYTK, ELAN, PTCT, and ADMAShould you be buying Immunocore stock or one of its competitors? The main competitors of Immunocore include Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Grifols (GRFS), Nuvalent (NUVL), Krystal Biotech (KRYS), Verona Pharma (VRNA), Cytokinetics (CYTK), Elanco Animal Health (ELAN), PTC Therapeutics (PTCT), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry. Immunocore vs. Telix Pharmaceuticals Limited American Depositary Shares Blueprint Medicines Grifols Nuvalent Krystal Biotech Verona Pharma Cytokinetics Elanco Animal Health PTC Therapeutics ADMA Biologics Immunocore (NASDAQ:IMCR) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, community ranking, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment. Do insiders and institutionals have more ownership in IMCR or TLX? 84.5% of Immunocore shares are owned by institutional investors. 9.1% of Immunocore shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts recommend IMCR or TLX? Immunocore presently has a consensus target price of $65.64, indicating a potential upside of 123.86%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus target price of $22.00, indicating a potential upside of 19.83%. Given Immunocore's higher probable upside, research analysts plainly believe Immunocore is more favorable than Telix Pharmaceuticals Limited American Depositary Shares.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Immunocore 1 Sell rating(s) 4 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.54Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in IMCR or TLX? Immunocore received 66 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 73.68% of users gave Immunocore an outperform vote. CompanyUnderperformOutperformImmunocoreOutperform Votes7073.68% Underperform Votes2526.32% Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes4100.00% Underperform VotesNo Votes Which has preferable earnings & valuation, IMCR or TLX? Telix Pharmaceuticals Limited American Depositary Shares has higher revenue and earnings than Immunocore. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioImmunocore$310.20M4.73-$55.29M-$1.02-28.75Telix Pharmaceuticals Limited American Depositary Shares$783.21M7.90N/AN/AN/A Does the media favor IMCR or TLX? In the previous week, Immunocore had 3 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 9 mentions for Immunocore and 6 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Immunocore's average media sentiment score of 1.42 beat Telix Pharmaceuticals Limited American Depositary Shares' score of 0.61 indicating that Immunocore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Immunocore 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Telix Pharmaceuticals Limited American Depositary Shares 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is IMCR or TLX more profitable? Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Immunocore's net margin of -15.87%. Telix Pharmaceuticals Limited American Depositary Shares' return on equity of 0.00% beat Immunocore's return on equity.Company Net Margins Return on Equity Return on Assets Immunocore-15.87% -12.84% -5.09% Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A SummaryImmunocore and Telix Pharmaceuticals Limited American Depositary Shares tied by winning 7 of the 14 factors compared between the two stocks. Remove Ads Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IMCR vs. The Competition Export to ExcelMetricImmunocoreBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.47B$3.03B$5.68B$8.32BDividend YieldN/A1.54%4.55%4.02%P/E Ratio-30.8629.9524.5519.25Price / Sales4.73447.85395.7294.09Price / CashN/A168.6838.1634.64Price / Book3.954.227.064.46Net Income-$55.29M-$71.72M$3.19B$247.07M7 Day Performance3.31%-2.22%1.49%3.05%1 Month Performance0.38%-9.53%5.87%-2.85%1 Year Performance-53.10%-22.57%14.94%4.63% Immunocore Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IMCRImmunocore2.0142 of 5 stars$29.32-1.1%$65.64+123.9%-53.3%$1.48B$310.20M-30.86320Positive NewsTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$17.60+1.7%$22.00+25.0%N/A$5.93B$783.21M0.00N/AGap UpBPMCBlueprint Medicines2.9068 of 5 stars$92.14+2.9%$125.70+36.4%+9.5%$5.89B$508.82M-85.31640GRFSGrifols2.9824 of 5 stars$8.10+1.5%N/A+24.6%$5.57B$7.21B6.9226,300NUVLNuvalent1.9713 of 5 stars$77.02+0.0%$113.10+46.8%-0.6%$5.51BN/A-22.2040Positive NewsHigh Trading VolumeKRYSKrystal Biotech4.791 of 5 stars$186.89+4.2%$220.00+17.7%+16.2%$5.38B$290.52M62.51210Positive NewsVRNAVerona Pharma1.4825 of 5 stars$66.56+8.4%$69.14+3.9%+315.6%$5.38B$42.28M-34.6730Positive NewsCYTKCytokinetics4.3591 of 5 stars$44.91+1.2%$82.00+82.6%-30.9%$5.32B$18.47M-8.35250Positive NewsELANElanco Animal Health4.3755 of 5 stars$10.65+2.0%$15.17+42.5%-32.4%$5.27B$4.44B26.619,800PTCTPTC Therapeutics3.4987 of 5 stars$57.17+4.9%$64.00+11.9%+96.0%$4.51B$806.78M-9.621,410Positive NewsADMAADMA Biologics2.4532 of 5 stars$18.67+1.3%$22.50+20.5%+223.1%$4.41B$426.45M66.68530Positive News Remove Ads Related Companies and Tools Related Companies TLX Competitors BPMC Competitors GRFS Competitors NUVL Competitors KRYS Competitors VRNA Competitors CYTK Competitors ELAN Competitors PTCT Competitors ADMA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IMCR) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IMCR Stock Free IMCR Stock Alerts